GlycoMimetics Inc (STU:GKO)
€ 0.2905 -0.0145 (-4.75%) Market Cap: 19.25 Mil Enterprise Value: 5.78 Mil PE Ratio: 0 PB Ratio: 1.78 GF Score: 23/100

Q1 2019 GlycoMimetics Inc Earnings Call Transcript

May 02, 2019 / 12:30PM GMT
Release Date Price: €10.35 (-2.45%)
Operator

Good morning, and thank you all for joining GlycoMimetics First Quarter 2019 Conference Call. (Operator Instructions)

I would now like to turn the call over to Shari Annes of Investor Relations Group at GlycoMimetics. Please go ahead.

Shari Annes

Good morning. Today, we will highlight the key achievements of 2019's first quarter and update you on our key clinical development program. The press release we issued this morning on our Q1 financials is available on the new section of the company's website at www.glycomimetics.com. This call is being recorded. A dial-in phone replay will be available for 24 hours after the close of the call. The webcast replay will also be available on the Investor Relations section of the company's website for 30 days.

Joining me on the call today from GlycoMimetics are Rachel King, Chief Executive Officer; Brian Hahn, Senior VP and Chief Financial Officer; and Dr. Helen Thackray, Senior VP of Development and Chief Medical Officer.

We will

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot